Vitamin B2 Found to Fuel Cancer Cell Defenses—German Researchers Identify a Way to Turn It Against Them

Breakthrough in Cancer Cell Research

According to НВ — Техно: Scientists at the University of Würzburg in Germany have discovered that cancer cells rely on vitamin B2-also known as riboflavin-to build a protective shield against ferroptosis, a form of programmed cell death. Published in the journal Nature Cell Biology, this finding sheds light on how tumors survive under stress and opens new avenues for treatment.

Through a genetic screening that examined thousands of genes, the team found that riboflavin fuels the FSP1 protein, which plays a critical role in shielding cancer cells from ferroptosis. This protective process is driven by the RFK gene, which activates the necessary mechanisms to keep cells alive in harsh conditions.

New Hope for Cancer Therapy

In their experiments, the researchers tested a vitamin B2 analog called roseoflavin. Unlike natural riboflavin, this compound cannot support the protective function of FSP1, suggesting it could be used to weaken cancer cells. Notably, the human body cannot produce riboflavin on its own, making dietary intake or supplements essential for normal function-and a potential vulnerability to exploit.

Ferroptosis is already linked to strokes, neurodegenerative diseases, and tissue damage after transplants. This discovery may guide further studies into how these conditions intersect with cancer biology. The findings could lead to new treatment strategies that disable cancer's defenses, improving the effectiveness of existing therapies.

Identifying riboflavin's role in protecting cancer cells highlights the importance of studying cellular metabolism and how tumors adapt to stressful environments.

This research may also inspire the development of targeted drugs that block the riboflavin-FSP1 pathway, as well as updated dietary guidelines for cancer patients. By understanding how vitamins influence tumor survival, scientists hope to design smarter treatments that make cancer cells more vulnerable to destruction.

As researchers continue to explore the role of vitamins in cancer treatment, the case of vitamin B12 also presents an intriguing angle. Recent studies have revealed how vitamin B12 can be weaponized against brain cancer, highlighting the potential of dietary compounds in targeting malignant cells. This parallel research emphasizes the growing importance of understanding how various nutrients can impact cancer biology and treatment strategies.